AstraZeneca Net Worth 2006-2020 | AZN

Interactive chart of historical net worth (market cap) for AstraZeneca (AZN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AstraZeneca net worth as of January 20, 2021 is $134.75B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $134.747B $24.384B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $421.997B 19.91
Roche Holding AG (RHHBY) Switzerland $305.169B 0.00
Novartis AG (NVS) Switzerland $218.868B 16.69
Merck (MRK) United States $210.954B 14.45
Pfizer (PFE) United States $203.993B 12.88
AbbVie (ABBV) United States $195.120B 11.28
Eli Lilly (LLY) United States $182.487B 27.61
Novo Nordisk (NVO) Denmark $169.616B 27.08
Sanofi (SNY) $123.679B 14.70
GlaxoSmithKline (GSK) United Kingdom $96.503B 12.78
Bayer (BAYRY) Germany $59.012B 8.89
H Lundbeck (HLUYY) Denmark $7.210B 12.75
Innoviva (INVA) United States $1.290B 5.89